and somatic cell nuclear transfer (SCNT). SCNT offers the potential to overcome graft rejection by using the patient's own chromosomal genetic material to generate embryos (Fig. 1) and thus ...

Explore Brainstorm Cell Therapeutics' Q1 2025 earnings call highlights, including FDA clearance for their ALS Phase 3b trial, funding efforts, ...

They achieved this by lowering the temperature of the egg before nuclear transfer, a novel technique. Previous studies report adverse consequences in approximately 50% of the egg cells.

Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

Neuralink’s brain implant enables ALS patient to communicate using AI, thought-controlled typing, and a cloned voice despite ...